On November 10, 2020, the Centers for Medicare & Medicaid Services (CMS) announced that Medicare beneficiaries can receive coverage of monoclonal antibodies to treat COVID-19 with no cost-sharing during the public health emergency. This treatment can be received in doctors’ offices, nursing homes, infusion centers, and hospitals, as long as safety conditions can be met. CMS intends to issue billing and coding instructions to providers for these treatments soon. Healthcare providers who intend to administer these treatments must be enrolled to administer COVID-19 vaccines. More information is available in the related instructions.
By using this site, you agree to our updated Privacy Policy.
Necessary Cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytical Cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.
